{"name":"Panafina, Inc.","slug":"panafina-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RABI-767","genericName":"RABI-767","slug":"rabi-767","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"RABI-767","genericName":"RABI-767","slug":"rabi-767","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQTG1pVkREYUZOTnRpT2JYN2gzaUpPakR6M3JvUHM2SzlHbmtTYXkwZU9vOWVrTlh2UzRrclU4c0diczZyQjl2WkJYaDRkSzh0UWhRaHR6ejNiU0NaMmJEQ1l6VmJCS3hndlk3bDhQY2ZfS284QXpaYk9yMjQzNWlQUEdkR0hRT0dWRlY4TUJ5LUtpeFY0NDBIU3BBX1MwSUZsc0I1c0NRRm9uaFZtYl9yeFNzRi1BS1lhbzltS1NYaXZxMW51MEo1ZzlVUGZ3dEg5c0ZOT09rNjRYSXI0aHNrUjVOYk5wd3R2SEJMX3o3NkhGWlBwUDVuSjRoUWtDNzIwQm5LWG5ycEswamlBZktTQWhkZ2JHNGZySWc?oc=5","date":"2024-07-15","type":"regulatory","source":"Business Wire","summary":"Arrivo Announces FDA Fast Track Designation for RABI-767 for Patients with Acute Pancreatitis Predicted to Progress to Severe Disease - Business Wire","headline":"Arrivo Announces FDA Fast Track Designation for RABI-767 for Patients with Acute Pancreatitis Predicted to Progress to S","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}